Results 191 to 200 of about 15,332 (223)
Some of the next articles are maybe not open access.

Atazanavir Resensitizes Candida auris to Azoles

Antimicrobial Agents and Chemotherapy, 2023
Candida auris represents an urgent health threat. Here, we identified atazanavir as a potent drug capable of resensitizing C. auris clinical isolates to the activity of azole antifungals.
Yehia Elgammal   +2 more
openaire   +2 more sources

CANDIDA AURIS ENFEKSİYONLARI

2022
Candida auris is an emerging but important pathogen due to its ability to cause epidemics and antifungal resistance. This factor, which was first detected in 2009, has rapidly started to be seen globally, and there have been cases detected in our country in recent years. However, much remains unknown about this current global public health pathogen. In
KARAAYVAZ, Serhat, ALKAN, Sevil
openaire   +1 more source

Susceptibility Testing of Candida auris Isolates

2022
Susceptibility testing of isolates of Candida auris is helpful as a guide to the selection of the most appropriate antifungal agent for treatment as different clades and strains within clades often demonstrate markedly different susceptibility profiles.
Elizabeth M, Johnson, Andrew M, Borman
openaire   +2 more sources

Management of Candida auris

JAMA
This JAMA Insights Clinical Update discusses the diagnosis, treatment, prognosis, and infection-prevention measures for Candida auris.
Anastasia, Wasylyshyn, Emily K, Stoneman
openaire   +2 more sources

Innate immune response to Candida auris

Current Opinion in Microbiology
Candida auris, a newly emergent fungal species, has been spreading in health care systems and causing life-threatening infections. Intact innate immunity is essential for protection against many invasive fungal infections, including candidiasis. Here, we highlight recent studies exploring immune interactions with C.
Ashley M, Holt, Jeniel E, Nett
openaire   +2 more sources

Emergence of Candida auris in Russia

Journal of Hospital Infection, 2019
This paper reports the emergence of Candida auris infections in an intensive care unit at a hospital in Moscow. Forty-nine cases were diagnosed in 2016-2017, and the risk factors and antifungal susceptibilities are described. The 30-day all-cause mortality for 19 bloodstream infections in patients who did not receive appropriate antifungal therapy was ...
N E, Barantsevich   +9 more
openaire   +2 more sources

Sticky Candida auris

Nature Reviews Microbiology, 2023
openaire   +2 more sources

Tüm Yönleriyle Candida Auris

Candida auris’ in Biyolojisi ve Evrimi Ayşe KALKANCI Candida auris’ in Tanımlanması Sidre ERGANİŞ Candida auris’ in Antifungal Duyarlılığı Elif Ayça ŞAHİN Candida auris’ in Biyosidlere Duyarlılığı Ali ÖZTÜRK Candida auris’in Oluşturduğu Klinik Tablolar Dahili Bilimler Pınar AYSERT YILDIZ Candida auris’in Oluşturduğu Klinik Tablolar Cerrahi Bilimler Can
Sidre Erganiş   +6 more
openaire   +1 more source

Candida Auris Outbreak Investigation

American Journal of Infection Control, 2022
Kathy G. Lyons   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy